Literature DB >> 14508723

Alternative schedules with irinotecan.

Robert Diasio1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14508723     DOI: 10.1016/s0093-7754(03)00330-0

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  1 in total

1.  Irinotecan, continuous 5-fluorouracil, and low dose of leucovorin (modified FOLFIRI) as first line of therapy in recurrent or metastatic colorectal cancer.

Authors:  Myung-Ah Lee; Jae-Ho Byun; Byoung-Young Shim; In-Sook Woo; Jin-Hyung Kang; Young Seon Hong; Kyung Shik Lee; Myung Gyu Choi; Suk Kyun Chang; Seong Taek Oh; Sung Il Choi; Doo Suk Lee
Journal:  Korean J Intern Med       Date:  2005-09       Impact factor: 2.884

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.